Incorporation of chlorhexidine into a soft relining resin for denture stomatitis treatment

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

REBEC

Registry ID

RBR-2tgh47

Enrollment

Unknown

Registered

2020-07-06

Start date

2016-09-02

Completion date

Unknown

Last updated

2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomatitis, Denture

Interventions

Experimental group: 15 maxillary denture wearers diagnosed with denture stomatitis will receive rebase of their prosthesis with soft tissue conditioner. Control group: 15 maxillary denture wearers dia

Drug

D02.078.370.141.100

E06.780.346.760.471

Eligibility

Age

18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Healthy individuals of both genders; users of total maxillary prosthesis for at least 1 year; who present with denture stomatitis in mucosal areas underlying complete dentures. To participate in the research, patients must sign an informed consent form.

Exclusion criteria

Exclusion criteria: Immunocompromised patients with uncontrolled endocrinopathologies who use antibiotics and those undergoing radiotherapy or chemotherapy will be excluded.

Design outcomes

Primary

Measure	Time frame
Remission of denture stomatitis lesions expected	—

Secondary

Measure	Time frame
Pathogenic microbiota reduction of denture stomatitis verified by lower count of colony forming units	—

Countries

Brazil

Contacts

Public ContactDaniel;Marcela Telles;Michelon

Faculdade de Odontologia da UERJ;Faculdade de Odontologia da UERJ

daniel.moraes.telles@gmail.com;marcelamedeiros7@gmail.com+55-021-996072514;+55-021-998897351

Outcome results

None listed

Source: REBEC (via WHO ICTRP)